Natural anti-galactose α1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts
- 1 June 2002
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 10 (1) , 15-24
- https://doi.org/10.1016/s0966-3274(01)00044-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Galα(1,3)Gal Epitope in Porcine Small Intestinal SubmucosaTissue Engineering, 2000
- Differential immune responses to α-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantationJournal of Clinical Investigation, 2000
- ANTI-GAL ANTIBODY-MEDIATED ALLOGRAFT REJECTION IN ??1,3-GALACTOSYLTRANSFERASE GENE KNOCKOUT MICETransplantation, 1998
- A MURINE MODEL OF ANTIBODY-MEDIATED HYPERACUTE REJECTION BY GALACTOSE-??(1,3)GALACTOSE ANTIBODIES IN Gal o/o MICE1Transplantation, 1998
- Oocyte Galα1,3Gal Epitopes Implicated in Sperm Adhesion to the Zona Pellucida Glycoprotein ZP3 Are Not Required for Fertilization in the MouseJournal of Biological Chemistry, 1995
- Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humansImmunology Today, 1993
- CHARACTERIZATION OF HUMAN ANTI-PORCINE “NATURAL ANTIBODIES” RECOVERED FROM EX VIVO PERFUSED HEARTS—PREDOMINANCE OF IgM AND IgG2Transplantation, 1993
- Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces.Journal of Clinical Investigation, 1992
- Treatment of murine CD5− B cells with anti-lg, but not LPS, induces surface CD5: two B-cell activation pathwaysInternational Immunology, 1991
- A unique natural human IgG antibody with anti-alpha-galactosyl specificity.The Journal of Experimental Medicine, 1984